Fairmount Funds Management LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
FF Fairmount Funds Management LLC | Institutional Filer | ▲ 5.37% | $1.38B | 12 |
Current Portfolio Holdings
Showing all 12 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | GLTO | Galecto, Inc. | Healthcare | 8.7M | $225.7M | 16.30% |
| 2 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 2.5M | $212.9M | 15.38% |
| 3 | COGT | Cogent Biosciences, Inc. | Healthcare | 5.5M | $211.8M | 15.30% |
| 4 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 4.0M | $202.7M | 14.64% |
| 5 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 3.7M | $181.7M | 13.13% |
| 6 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 3.9M | $76.6M | 5.53% |
| 7 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 1.9M | $72.7M | 5.25% |
| 8 | JBIO | Jade Biosciences, Inc. | Healthcare | 4.6M | $64.0M | 4.62% |
| 9 | CBIO | Crescent Biopharma, Inc. | Healthcare | 2.7M | $50.5M | 3.65% |
| 10 | ZBIO | Zenas BioPharma, Inc. | Healthcare | 2.4M | $46.1M | 3.33% |
| 11 | APGE | Apogee Therapeutics, Inc. | Healthcare | 299K | $25.1M | 1.82% |
| 12 | IKT | Inhibikase Therapeutics, Inc. | Healthcare | 8.6M | $14.5M | 1.05% |
Showing 1 to 12 of 12 holdings